Raju Prasad, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 10,619 shares at $48.26 ($476K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Open-market sale of $476k CRSP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 750 | $0 | 0.0% |
| 2 | $48.26 | 4,021 | $194K | 40.7% |
| 3 | $48.26 | 5,848 | $282K | 59.3% |
| Total | $44.85 avg | 10,619 | $476K | 100% |
| Filing → |
| CRSP | SELL | 2026-01-08 | $3.3M | — | Filing → |
| CRSP | SELL | 2025-12-23 | $1.1M | — | Filing → |
| CRSP | SELL | 2025-03-24 | $181K | — | Filing → |